| Date Filed | Type | Description |
| 02/02/2023 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 01/09/2023 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 05/05/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 04/12/2022 |
4
| Brockstedt Dirk G. (Chief Scientific Officer) has filed a Form 4 on RAPT Therapeutics, Inc.|
Txns:
| Sold 2,647 shares
@ $23.05, valued at
$61k
Exercised 1,290 options to buy
@ $6.18, valued at
$8k
Exercised 1,357 options to buy
@ $6.18, valued at
$8.4k
|
|
| 03/21/2022 |
4
| Brockstedt Dirk G. (Chief Scientific Officer) has filed a Form 4 on RAPT Therapeutics, Inc.|
Txns:
| Paid exercise price by delivering 820 shares
@ $36.73, valued at
$30.1k
|
|
| 03/14/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 02/14/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 02/14/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 01/13/2022 |
4
| Brockstedt Dirk G. (Chief Scientific Officer) has filed a Form 4 on RAPT Therapeutics, Inc.|
Txns:
| Sold 2,648 shares
@ $32.16, valued at
$85.2k
Exercised 2,648 options to buy
@ $6.18, valued at
$16.4k
|
|
| 12/13/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 12/10/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 10/12/2021 |
4
| Brockstedt Dirk G. (Chief Scientific Officer) has filed a Form 4 on RAPT Therapeutics, Inc.|
Txns:
| Sold 2,647 shares
@ $30.78, valued at
$81.5k
Exercised 2,647 options to buy
@ $6.18, valued at
$16.4k
|
|
| 09/13/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 08/12/2021 |
4
| Brockstedt Dirk G. (Chief Scientific Officer) has filed a Form 4 on RAPT Therapeutics, Inc.|
Txns:
| Sold 2,647 shares
@ $31.19, valued at
$82.6k
Exercised 2,647 options to buy
@ $6.18, valued at
$16.4k
|
|
| 07/13/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 06/15/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 05/13/2021 |
4
| Brockstedt Dirk G. (Chief Scientific Officer) has filed a Form 4 on RAPT Therapeutics, Inc.|
Txns:
| Sold 2,648 shares
@ $18.19, valued at
$48.2k
Exercised 2,648 options to buy
@ $6.18, valued at
$16.4k
|
|
| 05/06/2021 |
4
| Brockstedt Dirk G. (Chief Scientific Officer) has filed a Form 4 on RAPT Therapeutics, Inc.|
Txns:
| Sold 2,084 shares
@ $21.56, valued at
$44.9k
|
|
| 02/17/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 02/01/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 01/06/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 12/31/2020 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 11/18/2020 |
4
| Brockstedt Dirk G. (Chief Scientific Officer) has filed a Form 4 on RAPT Therapeutics, Inc.|
Txns:
| Sold 9,877 shares
@ $17.01, valued at
$168k
Exercised 3,369 options to buy
@ $6.18, valued at
$20.8k
Exercised 6,508 options to buy
@ $6.3, valued at
$41k
|
|
| 11/03/2020 |
4
| Brockstedt Dirk G. (Chief Scientific Officer) has filed a Form 4 on RAPT Therapeutics, Inc.|
Txns:
| Sold 1,910 shares
@ $28.06, valued at
$53.6k
|
|
| 08/18/2020 |
4
| Brockstedt Dirk G. (Chief Scientific Officer) has filed a Form 4 on RAPT Therapeutics, Inc.|
Txns:
| Sold 1,502 shares
@ $23.13, valued at
$34.7k
Sold 8,375 shares
@ $24.07, valued at
$201.6k
Exercised 9,877 options to buy
@ $6.18, valued at
$61k
|
|
| 05/18/2020 |
4
| Brockstedt Dirk G. (Chief Scientific Officer) has filed a Form 4 on RAPT Therapeutics, Inc.|
Txns:
| Sold 9,877 shares
@ $15, valued at
$148.2k
Exercised 9,877 options to buy
@ $6.18, valued at
$61k
|
|
| 01/31/2020 |
4
| Brockstedt Dirk G. (Chief Scientific Officer) has filed a Form 4 on RAPT Therapeutics, Inc.|
Txns:
| Granted 8,000 shares
@ $0
Granted 20,000 options to buy
@ $44.66, valued at
$893.2k
|
|
| 10/30/2019 |
3
| Form 3 - Initial statement of beneficial ownership of securities: |
| 01/03/2018 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 12/15/2017 |
4
| Brockstedt Dirk G. (EVP of Research and Dev.) has filed a Form 4 on ADURO BIOTECH, INC.|
Txns:
| Sold 65,223 shares
@ $8.1135, valued at
$529.2k
Exercised 64,108 options to buy
@ $1.45, valued at
$93k
|
|
| 12/04/2017 |
4
| Brockstedt Dirk G. (EVP of Research and Dev.) has filed a Form 4 on ADURO BIOTECH, INC.|
Txns:
| Sold 10,000 shares
@ $9.3998, valued at
$94k
Exercised 3,956 options to buy
@ $0.52, valued at
$2.1k
Exercised 6,044 options to buy
@ $0.52, valued at
$3.1k
|
|
| 11/14/2017 |
4
| Brockstedt Dirk G. (EVP of Research and Dev.) has filed a Form 4 on ADURO BIOTECH, INC.|
Txns:
| Sold 1,815 shares
@ $8.0132, valued at
$14.5k
Sold 4,062 shares
@ $8, valued at
$32.5k
Exercised 1,815 options to buy
@ $0.52, valued at
$943.8
Exercised 4,062 options to buy
@ $0.52, valued at
$2.1k
|
|
| 11/08/2017 |
4
| Brockstedt Dirk G. (EVP of Research and Dev.) has filed a Form 4 on ADURO BIOTECH, INC.|
Txns:
| Sold 4,123 shares
@ $8.0358, valued at
$33.1k
Exercised 4,123 options to buy
@ $0.52, valued at
$2.1k
|
|
| 10/04/2017 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
|